All Stories

  1. Female genital schistosomiasis, including zoonotic and hybrid schistosomes, and other cervicovaginal co-infections
  2. TRPtracker: a community database for monitoring praziquantel sensitivity at TRPMPZQ variants
  3. Association between female genital schistosomiasis and high-risk human papillomavirus among women of reproductive age in Zambia: the Schista study
  4. Acceptability and feasibility of one-stop home-based genital self-sampling for Female Genital Schistosomiasis, Human Papilloma Virus and self- testing for Trichomonas and HIV: The Zipime Weka Schista Study in Zambia
  5. Finding hybrid schistosomes in genital schistosomiasis: are we missing their clinical relevance?
  6. Association between female genital schistosomiasis and high-risk human papillomavirus among women of reproductive age in Zambia: the Schista study
  7. Isothermal Recombinase Polymerase Amplification based diagnostics for Female Genital Schistosomiasis and Human Papillomavirus: A Review of Combined Molecular Diagnostic Opportunities
  8. Visual diagnostics for female genital schistosomiasis and the opportunity for improvement using computer vision
  9. TRPtracker: a community database for monitoring praziquantel sensitivity at TRPMPZQ variants
  10. Closing the diagnostic gap in male genital schistosomiasis (MGS): current detection tools and novel strategies
  11. ‘Female Genital Schistosomiasis: Translational Challenges and Opportunities’ – outputs and actions from a consultative, collaborative and translational workshop
  12. Safety and efficacy of praziquantel 40 mg/kg versus 80 mg/kg in preschool-aged children with intestinal schistosomiasis in Uganda: a 2 × 2 factorial, double-blind, placebo-controlled, phase 2 randomised trial
  13. The first BILGENSA Research Network workshop in Zambia: identifying research priorities, challenges and needs in genital bilharzia in Southern Africa
  14. Point-of-care ultrasound reveals extensive pathology in Gabonese preschool-age children with urogenital schistosomiasis
  15. Protecting global health partnerships in the era of destructive nationalism
  16. Towards multilingualism in global health
  17. Female Genital Schistosomiasis (FGS) in a Nonendemic Setting: Retrospective Case-Notes Review of Schistosoma haematobium–Positive FGS Cases at the Hospital for Tropical Diseases, London, With a Pragmatic Clinical Pathway for Nonendemic Settings
  18. Landscape of guidance documents used at TropNet and GeoSentinel centres for the clinical management of schistosomiasis outside endemic areas: A systematic appraisal
  19. Description of four cases of male genital schistosomiasis (MGS) in children and adolescents, with a scoping review
  20. Association of female genital schistosomiasis and human papillomavirus and cervical pre-cancer: a systematic review
  21. Urogenital Schistosoma haematobium Cases at the Hospital for Tropical Diseases, London (1998-2018), and Suggested Pragmatic Follow-up Pathway for Non-endemic Settings
  22. Associations of poor water, sanitation, and hygiene and parasite burden with markers of environmental enteric dysfunction in preschool‐age children infected with Schistosoma mansoni in Uganda
  23. Combined interventions for the testing and treatment of HIV and schistosomiasis among fishermen in Malawi: a three-arm, cluster-randomised trial
  24. A health decision analytical model to evaluate the cost‐effectiveness of female genital schistosomiasis screening strategies: The female genital schistosomiasis SCREEN framework
  25. The first BILGENSA Research Network workshop in Zambia: identifying research priorities, challenges and needs in genital bilharzia in Southern Africa
  26. Zipime-Weka-Schista study protocol: a longitudinal cohort study and economic evaluation of an integrated home-based approach for genital multipathogen screening in women, including female genital schistosomiasis, human papillomavirus, Trichomonas and H...
  27. Female genital schistosomiasis burden and risk factors in two endemic areas in Malawi nested in the Morbidity Operational Research for Bilharziasis Implementation Decisions (MORBID) cross-sectional study
  28. Female genital schistosomiasis is a women’s issue, but men should not be left out: involving men in promoting care for female genital schistosomiasis in mainland Tanzania
  29. A cross‐sectional pilot household study of Schistosoma mansoni burden and associated morbidities in Lake Albert, Uganda
  30. Time to bring female genital schistosomiasis out of neglect
  31. Female Genital Schistosomiasis Lesion Resolution Post-Treatment with Praziquantel in Zambian Adults
  32. Schistosomiasis
  33. Building Partnerships to Empower Women Through Home Self-Sampling for Sexual and Reproductive Tract Infections
  34. Baseline Liver Ultrasound Findings in Preschool Children From the Praziquantel in Preschoolers Trial in Lake Albert, Uganda
  35. The Zipime-Weka-Schista study protocol: a longitudinal cohort study and economic evaluation of an integrated home-based approach for genital multi-pathogen screening in women, including female genital schistosomiasis, HPV, Trichomonas and HIV in Zambia
  36. Relationships Between Schistosoma Mansoni Infection Intensity and Nutritional Status and Anemia Among Preschool-aged Children in Uganda
  37. An Update on Schistosomiasis
  38. Visual diagnosis of female genital schistosomiasis in Zambian women from hand-held colposcopy: agreement of expert image review and association with clinical symptoms
  39. Perspective on Schistosomiasis Drug Discovery: Highlights from a Schistosomiasis Drug Discovery Workshop at Wellcome Collection, London, September 2022
  40. A 14-year follow-up of ultrasound-detected urinary tract pathology associated with urogenital schistosomiasis in women living in the Msambweni region of coastal Kenya
  41. Visual diagnosis of female genital schistosomiasis in Zambian women from hand-held colposcopy: agreement of expert image review
  42. The Presence of Hemoglobin in Cervicovaginal Lavage Is Not Associated With Genital Schistosomiasis in Zambian Women From the BILHIV Study
  43. A review of the genetic determinants of praziquantel resistance in Schistosoma mansoni: Is praziquantel and intestinal schistosomiasis a perfect match?
  44. Validation of the isothermal Schistosoma haematobium Recombinase Polymerase Amplification (RPA) assay, coupled with simplified sample preparation, for diagnosing female genital schistosomiasis using cervicovaginal lavage and vaginal self-swab samples
  45. Impact of a Novel, Low-Cost and Sustainable Health Education Program on the Knowledge, Attitudes, and Practices Related to Intestinal Schistosomiasis in School Children in a Hard-to-Reach District of Madagascar
  46. An update on female and male genital schistosomiasis and a call to integrate efforts to escalate diagnosis, treatment and awareness in endemic and non-endemic settings: The time is now
  47. The praziquantel in preschoolers (PIP) trial: study protocol for a phase II PK/PD-driven randomised controlled trial of praziquantel in children under 4 years of age
  48. The challenges for women’s health in sub-Saharan Africa: Lessons learned from an integrative multistakeholder workshop in Gabon
  49. Population pharmacokinetics and pharmacodynamics of investigational regimens’ drugs in the TB-PRACTECAL clinical trial (the PRACTECAL-PKPD study): a prospective nested study protocol in a randomised contr...
  50. Association of Female Genital Schistosomiasis With the Cervicovaginal Microbiota and Sexually Transmitted Infections in Zambian Women
  51. Association between cervical dysplasia and female genital schistosomiasis diagnosed by genital PCR in Zambian women
  52. Prevalence of intestinal schistosomiasis in pre-school aged children: a pilot survey in Marolambo District, Madagascar
  53. Five-Year Follow-Up on the Prevalence and Intensity of Infections of Schistosoma mansoni in a Hard-to-Reach District of Madagascar
  54. Cervicovaginal Immune Activation in Zambian Women With Female Genital Schistosomiasis
  55. Malaria and helminth co-infections in children living in endemic countries: A systematic review with meta-analysis
  56. Promoting gender, equity, human rights and ethnic equality in neglected tropical disease programmes
  57. Meningococcal carriage among Hajj pilgrims, risk factors for carriage and records of vaccination: a study of pilgrims to Mecca.
  58. Use of facemasks and other personal preventive measures by Hajj pilgrims and their impact on health problems during the Hajj
  59. Acceptability and feasibility of genital self-sampling for the diagnosis of female genital schistosomiasis: a cross-sectional study in Zambia
  60. Correction: Female genital schistosomiasis and HIV/AIDS: Reversing the neglect of girls and women
  61. Intestinal Schistosomiasis and Giardiasis Co-Infection in Sub-Saharan Africa: Can a One Health Approach Improve Control of Each Waterborne Parasite Simultaneously?
  62. Genital self-sampling compared with cervicovaginal lavage for the diagnosis of female genital schistosomiasis in Zambian women: The BILHIV study
  63. Intestinal Schistosomiasis and Giardiasis Co-Infection in Sub-Saharan Africa: Can a One Health Approach Improve Control of Each Waterborne Parasite Simultaneously?
  64. Population Pharmacokinetics of Praziquantel in Pregnant and Lactating Filipino Women Infected with Schistosoma japonicum
  65. Integration of prevention and control measures for female genital schistosomiasis, HIV and cervical cancer
  66. Application of a recombinase polymerase amplification (RPA) assay and pilot field testing for Giardia duodenalis at Lake Albert, Uganda
  67. Could This Child Have Schistosomiasis?
  68. Beyond the barrier: Female Genital Schistosomiasis as a potential risk factor for HIV-1 acquisition
  69. Acceptability and feasibility of genital self-sampling for the diagnosis of female genital schistosomiasis: a cross-sectional study in Zambia
  70. A cross-sectional study of periportal fibrosis and Schistosoma mansoni infection among school-aged children in a hard-to-reach area of Madagascar
  71. Schistosomiasis-associated pulmonary arterial hypertension: a systematic review
  72. Focused Assessment with Sonography for Urinary Schistosomiasis (FASUS)—pilot evaluation of a simple point-of-care ultrasound protocol and short training program for detecting urinary tract morbidity in highly endemic settings
  73. Implementation of a Highly Accurate Rapid Point-of-Care Test for Group a Streptococcus Detection at a Large Pediatric Emergency Department in South London
  74. Schistosoma mansoni Infection as a Predictor of Low Aerobic Capacity in Ugandan Children
  75. Female genital schistosomiasis and HIV/AIDS: Reversing the neglect of girls and women
  76. Schistosomiasis in Africa: Improving strategies for long-term and sustainable morbidity control
  77. Cognitive deficits and educational loss in children with schistosome infection—A systematic review and meta-analysis
  78. Praziquantel for the treatment of schistosomiasis during human pregnancy
  79. Paediatric and maternal schistosomiasis: shifting the paradigms
  80. High burden of Schistosoma mansoni infection in school-aged children in Marolambo District, Madagascar
  81. Point-of-care tests for infectious diseases: barriers to implementation across three London teaching hospitals
  82. One hundred years of neglect in paediatric schistosomiasis
  83. A call to strengthen the global strategy against schistosomiasis and soil-transmitted helminthiasis: the time is now
  84. Expanding Praziquantel (PZQ) Access beyond Mass Drug Administration Programs: Paving a Way Forward for a Pediatric PZQ Formulation for Schistosomiasis
  85. Predictors of fever-related admissions to a paediatric assessment unit, ward and reattendances in a South London emergency department: the CABIN 2 study
  86. Population Pharmacokinetics and Pharmacodynamics of Praziquantel in Ugandan Children with Intestinal Schistosomiasis: Higher Dosages Are Required for Maximal Efficacy
  87. A centenary of Robert T. Leiper's lasting legacy on schistosomiasis and a COUNTDOWN on control of neglected tropical diseases
  88. Point-of-Care Ultrasound Assessment of Tropical Infectious Diseases—A Review of Applications and Perspectives
  89. Anemia Among Children Exposed to Polyparasitism in Coastal Kenya
  90. Age-Stratified Profiles of Serum IL-6, IL-10, and TNF-α Cytokines Among Kenyan Children with Schistosoma haematobium, Plasmodium falciparum, and Other Chronic Parasitic Co-Infections
  91. Endomyocardial Fibrosis (EMF) in a Ugandan Child with Advanced Hepatosplenic Schistosomiasis: Coincidence or Connection?
  92. Diagnostics for schistosomiasis in Africa and Arabia: a review of present options in control and future needs for elimination
  93. Cross-sectional Study of the Burden of Vector-Borne and Soil-Transmitted Polyparasitism in Rural Communities of Coast Province, Kenya
  94. HIV and schistosomiasis co-infection in African children
  95. Human schistosomiasis
  96. Parasitic Helminths
  97. Development of a Specimen-Sparing Multichannel Bead Assay to Detect Antiparasite IgG4 for the Diagnosis of Schistosoma and Wuchereria Infections on the Coast of Kenya
  98. Preventive chemotherapy for schistosomiasis and soil-transmitted helminthiasis by cotreatment with praziquantel and albendazole
  99. Schistosomiasis
  100. Fecal Occult Blood and Fecal Calprotectin as Point-of-Care Markers of Intestinal Morbidity in Ugandan Children with Schistosoma mansoni Infection
  101. Schistosomiasis in African infants and preschool children: let them now be treated!
  102. Evaluation of the Health-related Quality of Life of Children in Schistosoma haematobium-endemic Communities in Kenya: A Cross-sectional Study
  103. Impact of Polyparasitic Infections on Anemia and Undernutrition among Kenyan Children Living in a Schistosoma haematobium-Endemic Area
  104. Impact of Drought on the Spatial Pattern of Transmission of Schistosoma haematobium in Coastal Kenya
  105. Measuring Fitness of Kenyan Children with Polyparasitic Infections Using the 20-Meter Shuttle Run Test as a Morbidity Metric
  106. Modeling the Effect of Chronic Schistosomiasis on Childhood Development and the Potential for Catch-Up Growth with Different Drug Treatment Strategies Promoted for Control of Endemic Schistosomiasis
  107. Flukes (Liver, Lung, and Intestinal)
  108. Schistosomiasis (Schistosoma)